Ionis Pharmaceuticals (IONS) Cash from Investing Activities (QoQ) (2009 - 2026)
Ionis Pharmaceuticals (IONS) Cash from Investing Activities (QoQ) (2009 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ionis Pharmaceuticals | 9.27 Bn | 7.36 Bn | 243.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 227.97% |
| Dec 31, 2025 | -559.29% |
| Sep 30, 2025 | 176.07% |
| Jun 30, 2025 | -170.44% |
| Mar 31, 2025 | 149.89% |
| Dec 31, 2024 | 120.02% |
| Sep 30, 2024 | -645.71% |
| Jun 30, 2024 | -17.94% |
| Mar 31, 2024 | 384.90% |
| Dec 31, 2023 | -138.88% |
| Sep 30, 2023 | -1.16% |
| Jun 30, 2023 | 121.35% |
| Mar 31, 2023 | -253.50% |
| Dec 31, 2022 | 215.34% |
| Sep 30, 2022 | -5,466.89% |
| Jun 30, 2022 | 98.85% |
| Mar 31, 2022 | -402.34% |
| Dec 31, 2021 | -22.02% |
| Sep 30, 2021 | 220.73% |
| Jun 30, 2021 | -228.12% |